Raymond W. Cohen, CEO of Symphony Medical, has more than 25 years of leadership and entrepreneurial experience in health care. He was for the past nine years the CEO of publicly-held Cardiac Science, Inc., a leading U.S. manufacturer of life-saving automatic public-access defibrillators that merged with Bothell, WA-based Quinton Cardiology Systems Inc. in 2005 and operates today under the name Cardiac Science Corporation, (Nasdaq: CSCX), where Cohen remains chairman of the board of directors. Cohen also serves as a member of the board of directors of BioLife Solutions, Inc, (Nasdaq OTC: BLFS.OB), a manufacturer of cryopreservation products used for human cell and tissue preservation, based in Owego, NY; and Syncroness, Inc., a privately-held contract engineering and product development firm based in Westminster, CO. He is also a member of the Advisory Board for the College of Osteopathic Medicine, Western University of Health Sciences in Pomona, CA.

When Cohen joined Cardiac Science in 1997 as its CEO, that company had no commercial products or revenue and only one issued patent. By 2004, under Cohen's leadership, it had grown to over $68 million in annual revenue, amassed an intellectual property portfolio of 77 issued patents and was ranked as the fourth fastest growing technology company in North America on the Deloitte & Touche Fast 500 list. In 2003, Cardiac Science was named Life Science Company of the Year by the American Electronics Association and Entrepreneurial Company of the Year by Frost and Sullivan in 2004.

Cohen is a graduate of State University of New York at Binghamton with a degree in business management and is an accredited public-company director having completed the certification program at UCLA’s Anderson Graduate School of Management.